RB1 and cancer: We observed that inactivation of Rb and TSC2 synergistically induce cell death due to cellular stress induced by altered metabolism, suggesting that agents that target the metabolic pathways may enhance TSC2 inactivation induced specific killing of the Rb mutant cancer cells by inducing increased cellular stress.